Stefano Paolucci1, Marco Iosa1, Danilo Toni2, Piero Barbanti3, Paolo Bovi4, Anna Cavallini5, E Candeloro5, Alessia Mancini2, Mauro Mancuso6, Serena Monaco7, Alessio Pieroni2, Serena Recchia8, Maria Sessa9, Davide Strambo9, Michele Tinazzi8, Giorgio Cruccu2, Andrea Truini10. 1. *Fondazione Santa Lucia IRCCS, Rome, Italy; 2. Department of Neurology and Psychiatry, Sapienza University, Rome, Italy; 3. IRCCS San Raffaele Pisana, Rome, Italy; 4. Ospedale Civile Maggiore Borgo Trento, Verona, Italy; 5. Casimiro Mondino, IRCCS Istituto Neurologico Nazionale, Pavia, Italy; 6. CRT-Rehabilitation Center of Terranuova Bracciolini, Arezzo, Italy; 7. Ospedale Civico, Palermo, Italy; 8. **Department of Neurological and Movement Sciences, Anatomy and Histology Section, University of Verona, Verona, Italy; 9. IRCCS Ospedale San Raffaele, Milano, Italy. 10. Department of Neurology and Psychiatry, Sapienza University, Rome, Italy; andrea.truini@uniroma1.it.
Abstract
OBJECTIVE: Pain prevalence data for patients at various stages after stroke. DESIGN: Repeated cross-sectional, observational epidemiological study. SETTING: Hospital-based multicenter study. SUBJECTS: Four hundred forty-three prospectively enrolled stroke survivors. METHODS: All patients underwent bedside clinical examination. The different types of post-stroke pain (central post-stroke pain, musculoskeletal pains, shoulder pain, spasticity-related pain, and headache) were diagnosed with widely accepted criteria during the acute, subacute, and chronic stroke stages. Differences among the three stages were analyzed with χ(2)-tests. RESULTS: The mean overall prevalence of pain was 29.56% (14.06% in the acute, 42.73% in the subacute, and 31.90% in the chronic post-stroke stage). Time course differed significantly according to the various pain types (P < 0.001). The prevalence of musculoskeletal and shoulder pain was higher in the subacute and chronic than in the acute stages after stroke; the prevalence of spasticity-related pain peaked in the chronic stage. Conversely, headache manifested in the acute post-stroke stage. The prevalence of central post-stroke pain was higher in the subacute and chronic than in the acute post-stroke stage. Fewer than 25% of the patients with central post-stroke pain received drug treatment. CONCLUSIONS: Pain after stroke is more frequent in the subacute and chronic phase than in the acute phase, but it is still largely undertreated.
OBJECTIVE:Pain prevalence data for patients at various stages after stroke. DESIGN: Repeated cross-sectional, observational epidemiological study. SETTING: Hospital-based multicenter study. SUBJECTS: Four hundred forty-three prospectively enrolled stroke survivors. METHODS: All patients underwent bedside clinical examination. The different types of post-stroke pain (central post-stroke pain, musculoskeletal pains, shoulder pain, spasticity-related pain, and headache) were diagnosed with widely accepted criteria during the acute, subacute, and chronic stroke stages. Differences among the three stages were analyzed with χ(2)-tests. RESULTS: The mean overall prevalence of pain was 29.56% (14.06% in the acute, 42.73% in the subacute, and 31.90% in the chronic post-stroke stage). Time course differed significantly according to the various pain types (P < 0.001). The prevalence of musculoskeletal and shoulder pain was higher in the subacute and chronic than in the acute stages after stroke; the prevalence of spasticity-related pain peaked in the chronic stage. Conversely, headache manifested in the acute post-stroke stage. The prevalence of central post-stroke pain was higher in the subacute and chronic than in the acute post-stroke stage. Fewer than 25% of the patients with central post-stroke pain received drug treatment. CONCLUSIONS:Pain after stroke is more frequent in the subacute and chronic phase than in the acute phase, but it is still largely undertreated.
Authors: M Iosa; A Lupo; G Morone; A Baricich; A Picelli; G Panza; N Smania; C Cisari; G Sandrini; S Paolucci Journal: Neurol Sci Date: 2017-10-30 Impact factor: 3.307
Authors: Andrea L Gilmore-Bykovskyi; Laura Block; Melissa Hovanes; Jacquelyn Mirr; Ann Kolanowski Journal: Res Gerontol Nurs Date: 2019-01-31 Impact factor: 1.571